| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.25B | +23.0% |
| Cost of Revenue | $306.5M | +14.3% |
| R&D Expense | $1.13B | +12.1% |
| SG&A Expense | $975.5M | +22.6% |
| Operating Income | -$176.9M | +37.3% |
| Pre-tax Income | -$377.4M | +13.0% |
| Income Tax | -$99.2M | -1575.4% |
| Net Income | -$278.2M | +36.8% |
| EPS (Basic) | -$2.18 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $966.4M | +18.9% |
| Accounts Receivable | $405.3M | +23.6% |
| Inventory | $78.5M | -11.9% |
| Current Assets | $3.30B | +10.5% |
| Total Assets | $4.24B | +10.7% |
| Current Liabilities | $1.19B | +22.6% |
| Total Liabilities | $4.17B | +3.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | -108.0% |
| Capital Expenditures | $34.3M | -44.9% |
| Investing Cash Flow | -$116.8M | +65.3% |
| Financing Cash Flow | $294.2M | +70.9% |
| Free Cash Flow | -$42.6M | -201.5% |
| +38.1% |
| EPS (Diluted) | -$2.18 | +38.1% |
| Stockholders' Equity |
| $67.1M |
| +130.4% |